Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 13.58 · gapped above the open, then crossed back over prior close. High/low 13.94 at 9:30 am ET, 13.26 at 10:45 am ET.
4D Molecular Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In October 2025, we announced a funding agreement with the Cystic Fibrosis Foundation ("CFF") to provide up to $11 million in additional funding, including $7.5 million in an initial tranche, which was completed in October 2025.”
FILING10-K0001193125-26-114075cik 0001650648
“In March 2022, we also entered into an Open Market Sales Agreement (the "Sales Agreement") with Jefferies LLC as sales agent to sell shares of our common stock, from time to time, with aggregate gross sales proceeds of up to $100.0 million pursuant to the S-3 Registration Statement as an "at-the-market" offering under the Securities Act (the "2022 ATM Offering Program").”
FILING10-K0001193125-26-114075cik 0001650648
“In June 2024, we entered into a Sales Agreement (the "Leerink Sales Agreement") with Leerink Partners LLC ("Leerink") as sales agent to sell shares of our common stock, from time to time, with aggregate gross sales proceeds of up to $250.0 million pursuant to a Registration Statement on Form S-3 that we filed with the SEC in February 2024 as an "at-the-market" offering under the Securities Act.”
FILING10-K0001193125-26-114075cik 0001650648
“In August 2019, we amended our agreement with uniQure (the "Amended uniQure Agreement") and entered into a separate new collaboration and license agreement with uniQure (the "Second uniQure Agreement").”
FILING10-K0001193125-26-114075cik 0001650648
“As partial consideration for the rights and licenses granted to AGT under the License Agreement, we received an upfront payment of $20.0 million.”
FILING10-K0001193125-26-114075cik 0001650648
“Otsuka made an upfront cash payment of $85 million and agreed to provide certain cost sharing for global development activities.”
FILING10-K0001193125-26-114075cik 0001650648
“For example, we rely on our exclusive license agreements with (i) U.C. Berkeley for certain rights with respect to the intellectual property covering certain compositions of matter and methods of use of certain AAV variants related to our 4D-710 and 4D-725 product candidates, and (ii) University of Pennsylvania for certain rights with respect to the intellectual property covering certain compositions of matter and methods of use of the short-form human complement factor H (sCFH) payload related to our 4D-175 product candidate.”
FILING10-K0001193125-26-114075cik 0001650648
“For example, we rely on our exclusive license agreements with (i) U.C. Berkeley for certain rights with respect to the intellectual property covering certain compositions of matter and methods of use of certain AAV variants related to our 4D-710 and 4D-725 product candidates, and (ii) University of Pennsylvania for certain rights with respect to the intellectual property covering certain compositions of matter and methods of use of the short-form human complement factor H (sCFH) payload related to our 4D-175 product candidate.”
FILING10-K0001193125-26-114075cik 0001650648
Watchlist prices, news filtered to it, and its next report on your desk.
4D Molecular Therapeutics, Inc. has 5 disclosed suppliers and 3 disclosed customers. Each one is named in an SEC filing, either 4D Molecular Therapeutics, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
FDMT (4D Molecular Therapeutics, Inc.) has 5 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: QURE −3.74%, in healthcare.